SCHEMBL7733872

SCHEMBL7733872

O=NN1CCCc2cc(F)ccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
NOTUM Q6P988 1/20 0.46
HDAC1 Q13547 2/20 0.46
HDAC6 Q9UBN7 2/20 0.46
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
ALOX12 P18054 1/20 0.43
KDM4C Q9H3R0 1/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
CNR2 P34972 1/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
KCNQ2 O43526 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM3 P20309 1/20 0.38
ROCK1 Q13464 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15597739 0.90 ALDH1A1 (0.53) ALDH1A1NOTUMHDAC1HDAC6PDK1
SCHEMBL8554737 0.76 ALDH1A1 (0.66) ALDH1A1NOTUMHDAC1HDAC6PDK1
SCHEMBL10424055 0.76 ALDH1A1 (0.53) ALDH1A1NOTUMHDAC1HDAC6HTR2C
SCHEMBL29933410 0.75 ALDH1A1 (0.60) ALDH1A1NOTUMALOX12CHRM2CHRM3
SCHEMBL1437753 0.75 ALDH1A1 (0.60) ALDH1A1NOTUMALOX12CHRM2CHRM3
SCHEMBL24316039 0.74 NOTUM (0.46) ALDH1A1NOTUMHDAC1HDAC6PDK1
SCHEMBL7257879 0.74 NOTUM (0.46) ALDH1A1NOTUMHDAC1HDAC6PDK1
SCHEMBL2625790 0.74 ALDH1A1 (0.58) ALDH1A1NOTUMHDAC1HDAC6PDK1
SCHEMBL8728886 0.73 HDAC1 (0.52) ALDH1A1NOTUMHDAC1HDAC6PDK1
SCHEMBL12742058 0.73 ALDH1A1 (0.58) ALDH1A1NOTUMALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828325-B2 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression SOLVAY PHARMACEUTICALS B.V. (CH) 2004-12-07 US disclosed